Wang, Ying

Basic Info

Academic Rank:

Assistant Professor, Department of Pathology and Laboratory Medicine


Centre for Heart Lung


St. Paul’s Hospital

Short Bio

Dr. Wang received her BSc (2006) and MSc (2008) in Pharmaceutical Sciences, Wuhan University. She worked as an Associate Scientist at Shanghai ChemPartner Co. Ltd (2008-2009), where her research focused on pre-clinical screening for anti-cancer pharmaceutical candidates using human tumor biospecimens. She continued her academic training at University of British Columbia in 2009 as a PhD student at Faculty of Pharmaceutical Sciences and then as a Postdoctoral Fellow at the Centre for Heart Lung Innovation in 2014. She was awarded the Elaine W. Raines Early Career Investigator Award by the American Heart Association in 2016 and joined the PlaqOmics Leducq Foundation Trans-Atlantic Network in 2018 during her Postdoctoral training at Stanford University. Dr. Wang began her academic appointment as Assistant Professor at the University of British Columbia in March 2021. So far, she has received funding from CIHR, SSHRC, CFI, and Fondation Leducq, as well as awards from Faculty of Medicine and the Heart and Stroke Foundation of Canada. Dr. Wang was recently appointed as the Director of our Cardiovascular Tissue Registry.


Academic Backgrounds

  • Post-doctoral fellow, Department of Vascular Surgery, Stanford University, Stanford, US. 2020
  • Post-doctoral fellow, Department of Medicine, University of British Columbia, Vancouver. 2017
  • PhD, Pharmaceutical Sciences, University of British Columbia. 2014
  • MSc, Pharmacology, Wuhan University, China. 2008
  • BSc, Pharmaceutical Sciences, Wuhan University, China. 2006

Awards & Recognition

Selected Publications

For a list of Dr. Wang’s publications, click


Current Openings & Opportunities

Current Projects In My Lab include


Dr. Wang’s research is focused on studying cell-cell and cell-microenvironment interactions to determine why diseased cells accumulate in the atherosclerotic lesions and how we can remove them. ‘Functional omics on a tissue slide’ is the current theme of Dr. Wang’s research. With a combination of biobank associated studies, spatial biology technology, and molecular biology, researchers in the Wang Lab aim to develop new therapeutic and diagnostic tools for better treatment and prediction of atherosclerotic disease.